This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Mode of action of thrombolytics

Authoring team

All thrombolytics in use act as plasminogen activators:

  • plasminogen is the inactive precursor of plasmin
  • plasminogen and its natural activator, tPA, both bind to fibrin clots resulting in a cascade of local plasmin production
  • streptokinase activates plasminogen throughout the circulation
  • plasmin is a serine protease which is able to degrade fibrin, yielding soluble fibrin degradation products

Thrombolytics act at three sites:

  • thrombus
  • haemostatic plugs
  • streptokinase produces a systemic impairment of haemostasis

Reference:

  1. Muhammad U. Baig, Jeffrey Bodle. Thrombolytic Therapy. StatPearls Publishing 2024 Jan

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.